Literature DB >> 23526577

Bone and metabolic markers in women with recurrent calcium stones.

Miguel Angel Arrabal-Polo1, Miguel Arrabal-Martin, Salvador Arias-Santiago.   

Abstract

PURPOSE: The target of our work was to study several biochemical parameters in phospho-calcic and bone metabolism in blood and urine and the bone mineral density of women with recurrent calcium nephrolithiasis.
MATERIALS AND METHODS: We conducted a cross-sectional study with a control group of 85 women divided into 3 groups: group 1 consisted of 25 women without a history of nephrolithiasis, group 2 consisted of 35 women with only one episode of calcium nephrolithiasis, and group 3 consisted of 25 women with a history of recurrent calcium nephrolithiasis. Blood and urine biochemical study was performed, including markers related to lithiasis, and a bone mineral density study was done by use of bone densitometry.
RESULTS: Patients in group 3 showed statistically significantly elevated calciuria (15.4 mg/dL), fasting calcium/creatinine ratio (0.14), and 24-hour calcium/creatinine ratio (0.21) compared with groups 1 and 2. Moreover, this group of women with recurrent calcium nephrolithiasis had significantly elevated values of beta-crosslaps, a bone resorption marker, compared with groups 1 and 2 (p=0.000) and showed more bone mineral density loss than did these groups.
CONCLUSIONS: Recurrent calcium nephrolithiasis in women has a significant association with bone mineral density loss and with values of calciuria, both fasting and 24-hour.

Entities:  

Keywords:  Bone density; Calcium; Urolithiasis; Women

Year:  2013        PMID: 23526577      PMCID: PMC3604571          DOI: 10.4111/kju.2013.54.3.177

Source DB:  PubMed          Journal:  Korean J Urol        ISSN: 2005-6737


  22 in total

Review 1.  Possibilities for preventing recurrent calcium stone formation: principles for the metabolic evaluation of patients with calcium stone disease.

Authors:  H G Tiselius
Journal:  BJU Int       Date:  2001-07       Impact factor: 5.588

Review 2.  Osteoporosis and urolithiasis.

Authors:  R Caudarella; F Vescini; A Buffa; G La Manna; S Stefoni
Journal:  Urol Int       Date:  2004       Impact factor: 2.089

3.  Biochemical determinants of severe lithogenic activity in patients with idiopathic calcium nephrolithiasis.

Authors:  Miguel Angel Arrabal-Polo; Miguel Arrabal-Martin; Tomas de Haro-Muñoz; Antonio Poyatos-Andujar; Francisco Palæo-Yago; Armando Zuluaga-Gomez
Journal:  Urology       Date:  2011-09-09       Impact factor: 2.649

4.  [Metabolic risk factors in calcium urolithiasis according to gender and age of the patients].

Authors:  J A Lancina Martín; J Rodríguez-Rivera García; S Novás Castro; I Rodríguez Gómez; E Fernández Rosado; L Alvarez Castelo; A Blanco Díez; M González Martín
Journal:  Actas Urol Esp       Date:  2002-02       Impact factor: 0.994

Review 5.  [Evaluation of renal stone disease: metabolic study].

Authors:  R Areses Trapote; M A Urbieta Garagorri; M Ubetagoyena Arrieta; T Mingo Monge; D Arruebarrena Lizarraga
Journal:  An Pediatr (Barc)       Date:  2004-11       Impact factor: 1.500

6.  Comparison of metabolic risk factors in patients with recurrent urolithiasis stratified according to age and gender.

Authors:  T Yagisawa; T Hayashi; A Yoshida; C Kobayashi; H Okuda; N Ishikawa; H Toma
Journal:  Eur Urol       Date:  2000-09       Impact factor: 20.096

Review 7.  Idiopathic calcium nephrolithiasis.

Authors:  M Marangella; C Vitale; C Bagnis; M Bruno; A Ramello
Journal:  Nephron       Date:  1999       Impact factor: 2.847

8.  Hypercalciuria is a common and important finding in postmenopausal women with osteoporosis.

Authors:  Sandro Giannini; Martino Nobile; Luca Dalle Carbonare; Maria Giuseppina Lodetti; Stefania Sella; Gabriele Vittadello; Nadia Minicuci; Gaetano Crepaldi
Journal:  Eur J Endocrinol       Date:  2003-09       Impact factor: 6.664

9.  Bone mineral density changes in hypercalciuretic osteoporotic men treated with thiazide diuretics.

Authors:  Isabelle Legroux-Gerot; Lionel Catanzariti; Xavier Marchandise; Bernard Duquesnoy; Bernard Cortet
Journal:  Joint Bone Spine       Date:  2004-01       Impact factor: 4.929

10.  Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors.

Authors:  Renata Caudarella; Fabio Vescini; Angela Buffa; Giuseppe Sinicropi; Elisabetta Rizzoli; Gaetano La Manna; Sergio Stefoni
Journal:  J Nephrol       Date:  2003 Mar-Apr       Impact factor: 3.902

View more
  4 in total

1.  The importance of urinary calcium in postmenopausal women with osteoporotic fracture.

Authors:  Miguel Angel Ochoa-Hortal Rull; María Del Carmen Cano-García; Miguel Arrabal-Martín; Miguel Angel Arrabal-Polo
Journal:  Can Urol Assoc J       Date:  2015 Mar-Apr       Impact factor: 1.862

2.  Bone resorption in dogs with calcium oxalate urolithiasis and idiopathic hypercalciuria.

Authors:  Austin C Luskin; Jody P Lulich; Sarah C Gresch; Eva Furrow
Journal:  Res Vet Sci       Date:  2019-01-04       Impact factor: 2.534

Review 3.  Nephrolithiasis, bone mineral density, osteoporosis, and fractures: a systematic review and comparative meta-analysis.

Authors:  P Lucato; C Trevisan; B Stubbs; B M Zanforlini; M Solmi; C Luchini; G Girotti; S Pizzato; E Manzato; G Sergi; S Giannini; M Fusaro; N Veronese
Journal:  Osteoporos Int       Date:  2016-06-11       Impact factor: 4.507

4.  Low Oxalobacter Formigenes Colonization is Associated with Reduced Bone Mineral Density in Urinary Stone Forming Patients.

Authors:  Sadrettin Pence; Ibrahim Ikizceli; Emin Ozbek; Necip Ozan Tiryakioglu; Hilal Eren; Emre Can Polat; Halime Hanım Pence
Journal:  Curr Urol       Date:  2015-11-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.